CTT PHARMACEUTICAL HOLDINGS, INC.

Gold and Silver Ores·TAMPA, FL

CEO

Ctt Pharmaceutical Holdings, Inc.

Summary Financials

Revenue

—

Adj. EBITDA

$51,454

FY 2014

Net Income

-$18,911

FY 2014

EPS (Diluted)

-$0.11

FY 2013

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$81,179

FY 2014

Total Debt

—

Net Cash

$81,179

Enterprise Value

—

Debt / EBITDA

-1.6x

FY 2014

EV / EBITDA

—

Employees

—

Revenue

—

Adj. EBITDA

$51,454

FY 2014

Net Income

-$18,911

FY 2014

EPS (Diluted)

-$0.11

FY 2013

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$81,179

FY 2014

Total Debt

—

Net Cash

$81,179

Enterprise Value

—

Debt / EBITDA

-1.6x

FY 2014

EV / EBITDA

—

Employees

—